Phathom Pharmaceuticals (PHAT) Debt Ratio (2018 - 2026)

Phathom Pharmaceuticals (PHAT) has reported Debt Ratio for 8 consecutive years, with 0.5 the latest figure, recorded in Q2 2026.

• In Q2 2026, Debt Ratio fell 38.62% year-over-year to 0.5; the TTM figure through Jun 2026 stood at 0.5 (down 38.62% YoY), while the FY2025 annual figure was 0.81, up 51.55% from the prior year.
• Debt Ratio fell to 0.5 in Q2 2026 per PHAT's latest filing, from 0.54 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.86 in Q3 2025 and bottomed at 0.33 in Q4 2023.
• Historically, Debt Ratio has averaged 0.56 across 5 years, with a median of 0.53 in 2024.
• Annual changes were most pronounced in 2022 — Debt Ratio soared 217.78% — and 2023, when it plunged 42.38%.
• Phathom Pharmaceuticals' Debt Ratio stood at 0.58 in 2022, then slumped by 42.38% to 0.33 in 2023, then jumped by 59.84% to 0.53 in 2024, then jumped by 51.55% to 0.81 in 2025, then plunged by 37.63% to 0.5 in 2026.
• Business Quant data shows PHAT's Debt Ratio at 0.5 in Q2 2026, 0.54 in Q1 2026, and 0.81 in Q4 2025.